SS-31 (Elamipretide): FDA-Approved Mitochondrial Peptide - Benefits, Dose, Frequency, Cycles скачать в хорошем качестве

SS-31 (Elamipretide): FDA-Approved Mitochondrial Peptide - Benefits, Dose, Frequency, Cycles

SS-31 (Elamipretide) is quickly becoming one of the most talked-about longevity peptides—a mitochondrial-optimizing compound now FDA-approved for Barth Syndrome and studied for brain health, kidney protection, chronic fatigue, and even slowing key drivers of aging. But what’s real? What’s hype? And how do you actually dose this safely? In this video, Dr. Quinn Stillson (MD + strength coach) breaks down the real science behind SS-31, including how it stabilizes cardiolipin, restores mitochondrial function, boosts ATP production, and may counteract several root causes of aging. We cover the human data, the animal evidence, the anti-aging implications, and everything you need to know before considering this peptide for energy, recovery, or long-term healthspan. 💥 Whether you're exploring mitochondrial support, reversing age-related fatigue, looking to protect your brain and kidneys, or building a serious longevity stack—this is the deep dive you need on SS-31. 🔬 In this video, you’ll learn: ✅ How SS-31 targets cardiolipin to stabilize mitochondrial membranes ✅ Why mitochondrial decline is a root cause of aging—and how SS-31 may help ✅ Evidence for improving ATP production, resilience, frailty scores, and exercise capacity ✅ FDA-approved use in Barth Syndrome + why that matters for longevity ✅ Preclinical data on dementia, TBI recovery, CKD, diabetes, and age-related decline ✅ Daily vs weekly dosing, ideal ranges, timing, and cycle length ✅ Why oral SS-31 is unlikely effective (and what forms are) ✅ How to source SS-31 responsibly with third-party-tested pharmacies ✅ Who may benefit most—from older adults to people with measurable mitochondrial dysfunction 🎯 Best for: – Anyone building a longevity or anti-aging protocol – Individuals with fatigue, brain fog, or mitochondrial decline – Athletes seeking better recovery and energy output – People with kidney, metabolic, or neurodegenerative risk – Clinicians exploring mitochondrial-targeted therapies – Biohackers wanting a high-level, evidence-based breakdown 📍 Timestamps 00:00 New FDA-Approved Peptide - SS-31 00:46 How SS-31 Works - Stabilizing the Mitochondria 04:08 FDA-Approved Use Case for SS-31 - Barth Syndrome 05:33 SS-31 for Dementia and Traumatic Brain Injuries (TBIs) 07:43 SS-31 for CKD (Chronic Kidney Disease) and Diabetes 09:21 SS-31 for Chronic Fatigue 10:12 SS-31 for Anti-Aging and Longevity 12:12 Safety Concerns for SS-31? 14:36 Who Should Consider Taking SS-31? 17:28 Best Form of SS-31 - Is it Orally Bioavailable? 19:02 Optimal Dose of SS-31 - Balancing Cost, Safety, and Efficacy 22:48 Frequency of SS-31 Injections - Daily vs Weekly? 24:50 Cycle Length and Sourcing for SS-31 ▶️ Related Video: TB-4 & TB-500 →    • TB-500 & TB-4: Everything You Need to Know...   ▶️ Subscribe for more: Weekly videos on peptides, recovery, and functional medicine. 🔔 Next: MOTS-c & CB-4211 deep dive (don’t miss it). ⚠️ Medical Disclaimer: This video is for educational purposes only. SS-31 is FDA-approved only for Barth Syndrome; all other uses are off-label. Always consult a qualified provider before starting any peptide or medication. #SS31 #Elamipretide #LongevityPeptides #AntiAging #Mitochondria #MitochondrialPeptide #MitochondrialSupport #EnergyOptimization #FunctionalMedicine #HealthyAging